What Soon-Shiong has delivered, Encanta’s RSV antiviral, and other biotech news from The Readout
Julio Cortez/AP
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Washington’s vaccine wars are escalating again as Senate Democrats seek to build a paper trail around Health Secretary Robert F. Kennedy Jr.’s controversial overhaul of the CDC’s vaccine advisory committee.
Also, Enanta’s pushing forward with its RSV antiviral, we take a critical look at Patrick Soon-Shiong’s pancreatic cancer claims, and some news from longevity player Cambria.
